CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
43.30
-1.43 (-3.20%)
At close: Dec 5, 2025, 4:00 PM EST
43.67
+0.37 (0.85%)
After-hours: Dec 5, 2025, 6:24 PM EST

CG Oncology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-151.48-88.04-48.61-35.44-12.84
Depreciation & Amortization
0.60.030.020.020.01
Other Amortization
--00.010.01
Loss (Gain) From Sale of Investments
-0.71-4.99-2.88--
Stock-Based Compensation
24.4811.41.530.681.11
Other Operating Activities
-0.83-0.020.820.50.02
Change in Accounts Receivable
-0.71-0.69---
Change in Accounts Payable
4.283.282.01-0.020.58
Change in Other Net Operating Assets
7.970.321.434.46-2.55
Operating Cash Flow
-116.79-78.71-45.68-29.8-13.65
Capital Expenditures
-0.34-0.23--0.01-0.1
Investment in Securities
-137.11-300.53-121.2-55.34-
Investing Cash Flow
-159.41-300.76-121.2-55.35-0.1
Long-Term Debt Issued
----15.2
Long-Term Debt Repaid
--0.37-16.29--
Net Debt Issued (Repaid)
--0.37-16.29-15.2
Issuance of Common Stock
278.22632.072.080.170.25
Other Financing Activities
-0.28-3.42-3.83-0.47-
Financing Cash Flow
277.94628.2887119.6915.45
Net Cash Flow
1.73248.8-79.8834.541.7
Free Cash Flow
-117.13-78.95-45.68-29.82-13.75
Free Cash Flow Margin
-5387.67%-6931.26%-22391.67%-15611.52%-132.76%
Free Cash Flow Per Share
-1.57-1.26-10.55-7.97-3.77
Cash Interest Paid
--0.381.090.31
Levered Free Cash Flow
-77.78-59.08-28.07-16.95-
Unlevered Free Cash Flow
-77.78-59.08-28.07-16.96-
Change in Working Capital
11.162.913.444.44-1.97
Source: S&P Capital IQ. Standard template. Financial Sources.